Technical Analysis for IPHA - Innate Pharma S.A.

Grade Last Price % Change Price Change
grade B 5.36 -19.76% -1.32
IPHA closed down 19.76 percent on Wednesday, April 1, 2020, on 63 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical IPHA trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Stochastic Reached Overbought Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Crossed Above 50 DMA Bullish -19.76%
Calm After Storm Range Contraction -19.76%
Outside Day Range Expansion -19.76%
Wide Bands Range Expansion -19.76%
Up 3 Days in a Row Strength -19.76%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells. The company was founded by Hervé Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié and François Romagné on September 15, 1999 and is headquartered in Marseille, France.
Medicine Biopharmaceutical Cancer Medical Specialties Immunology Immunotherapy Antibodies Immune System Antibody Cancer Treatment Inflammatory Diseases Monoclonal Antibody

Is IPHA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.24
52 Week Low 3.3
Average Volume 18,234
200-Day Moving Average 0.00
50-Day Moving Average 6.58
20-Day Moving Average 5.38
10-Day Moving Average 5.11
Average True Range 0.81
ADX 17.06
+DI 26.65
-DI 27.37
Chandelier Exit (Long, 3 ATRs ) 5.47
Chandelier Exit (Short, 3 ATRs ) 5.72
Upper Bollinger Band 7.58
Lower Bollinger Band 3.19
Percent B (%b) 0.49
BandWidth 81.68
MACD Line -0.29
MACD Signal Line -0.50
MACD Histogram 0.2089
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.52
Resistance 3 (R3) 7.56 6.87 7.16
Resistance 2 (R2) 6.87 6.32 6.86 7.04
Resistance 1 (R1) 6.12 5.98 5.78 6.08 6.92
Pivot Point 5.43 5.43 5.26 5.42 5.43
Support 1 (S1) 4.68 4.88 4.34 4.64 3.80
Support 2 (S2) 3.99 4.54 3.98 3.68
Support 3 (S3) 3.24 3.99 3.56
Support 4 (S4) 3.20